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is not required here to obtain valid estimates [3,4]. Of note, neither form
of modelling addresses potential underestimation of causal associations,
caused by competing events ‘masking’ the impact of the risk factor on
the phenotype of interest.
Practically, this means that the causal relationship between AF and
dementia is best determined by the cause-speciﬁc hazard, using CoxTo the Editor,
Recently in the International Journal of Cardiology, Marzona et al. re-
ported the association between atrial ﬁbrillation (AF) and risk of de-
mentia in a population-based cohort [1]. Using Cox's cause-speciﬁc
hazard models, the authors found that atrial ﬁbrillation is signiﬁcantly
associated with risk of dementia in their study population. However,
after performing additional (subdistribution hazard) competing risk
modelling they conclude that “the association between AF and demen-
tia was no longer statistically signiﬁcant when death was considered a
competing risk”. We feel that this conclusion does not do justice to the
presented data, because of differences in the interpretation of the
cause-speciﬁc and subdistribution hazards that are not discussed in
the paper.
While competing riskmodelling, for examplewith the subdistribution
hazard of Fine andGray'smodels [2], can be valuable in prognostic studies,
they are less appropriate for determining aetiological associations in the
presence of strong competing risks [3,4]. The fundamental issue with
competing risk is that one of the main assumptions for censoring, inde-
pendence of reasons for censoring, is no longer met. For estimating prog-
nosis, ignoring the fact that death precludes development of an illness
overestimates an individual's risk, and one would therefore intuitively
want to keep a person in the risk set after occurrence of this competing
event. Conversely, in aetiological studies, the primary interest lies in de-
termining the (relative) risk of disease in those who are still at risk of
the disease at a certain time-point. These cause-speciﬁc hazards are ob-
tained from a Cox model, in which individuals are censored at time ofrd.2016.09.106.
logy, Erasmus Medical Centre,
).
land Ltd. This is an open access articl(competing) event. Importantly, independence of reasons for censoring
models [3,4]. As such, ﬁndings presented by Marzona et al. add to vari-
ous previous studies to establish a ﬁrm association of AFwith risk of de-
mentia [5,6], and underline that these associations extend to the elderly
population. Although randomised trials assessing effects of treatment of
AF on (surrogate markers of) dementia risk are still lacking, Marzona
et al. rightly emphasise that current “anticoagulant treatment in pa-
tients with AF is still unsatisfactory” in view of available evidence
from randomised controlled trials for other disease outcomes. This
study in line with others merits emphasis on adherence to current
guidelines for AF treatment, if not for prevention of dementia, then for
one of life's alternative hazards in which AF plays part.
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